On heels of Super Bowl ad, Hologic inks title sponsorship deal with Women’s Tennis Association Tournews2022-03-03T23:05:15+00:00March 3rd, 2022|Fierce Pharma|
Billionaire Sackler family enters $6B opioid deal with support from holdout statesnews2022-03-03T19:46:59+00:00March 3rd, 2022|Fierce Pharma|
Amgen, NHS strike deal to expand Lumykras access in UK as watchdog weighs its meritsnews2022-03-03T19:41:40+00:00March 3rd, 2022|Fierce Pharma|
Regeneron loses bid to scrap infringement lawsuit linked to COVID antibody cocktailnews2022-03-03T18:27:55+00:00March 3rd, 2022|Fierce Pharma|
Biogen starts layoff round as the Aduhelm maker struggles with Alzheimer’s rolloutnews2022-03-03T16:22:45+00:00March 3rd, 2022|Fierce Pharma|
Roche, Sanofi, Novo Nordisk and more pledge support to Ukraine as industry condemns Russian invasionnews2022-03-03T15:20:03+00:00March 3rd, 2022|Fierce Pharma|
Bayer plots $1.6B investment at German pharma manufacturing sites, with digital transformation a key componentnews2022-03-03T14:59:29+00:00March 3rd, 2022|Fierce Pharma|
Biogen’s Aduhelm still has blockbuster potential if everything breaks right: analystnews2022-03-03T14:33:50+00:00March 3rd, 2022|Fierce Pharma|
Novo Nordisk, citing strong Wegovy demand, doubles 2025 sales target for obesity franchisenews2022-03-03T14:04:50+00:00March 3rd, 2022|Fierce Pharma|
Stevanato reels in $95M federal contract to produce drug vials for pandemic prep effortsnews2022-03-03T13:15:58+00:00March 3rd, 2022|Fierce Pharma|
